SKI Market

Indian Indices

Nifty

25,763.35 41.25
(0.16%)

Sensex

83,978.49 39.78
( 0.05%)

Bank Nifty

58,101.45 325.10
( 0.56%)

Nifty IT

35,653.10 -59.25
( -0.17%)

Global Indices

Nasdaq

47,357.62 -226.25
(-0.48%)

Dow Jones

6,873.20 12.00
(0.17%)

Hang Seng

52,282.77 957.16
(1.86%)

Nikkei 225

9,706.66 -10.59
(-0.11%)

Forex

USD-INR

88.57 0.35
(0.39%)

EUR-INR

102.67 0.05
(0.05%)

GBP-INR

116.69 0.04
(0.03%)

JPY-INR

0.58 0.00
(-0.51%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Gland Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

543245

INE068V01023

592.0923532

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GLAND

28.6

32492.44

EPS(TTM)

Face Value()

Div & Yield %

68.96

0.91

Back

Sunrakshakk Industries India standalone net profit rises 51.02% in the June 2025 quarter

Aug 14,2025

Net profit of Sunrakshakk Industries India rose 51.02% to Rs 0.74 crore in the quarter ended June 2025 as against Rs 0.49 crore during the previous quarter ended June 2024. Sales rose 1.94% to Rs 24.73 crore in the quarter ended June 2025 as against Rs 24.26 crore during the previous quarter ended June 2024.

Particulars	Quarter Ended
	Jun. 2025	Jun. 2024	% Var.
Sales	24.73	24.26	2
OPM %	14.88	12.86	-
PBDT	2.95	2.96	0
PBT	1.05	0.66	59
NP	0.74	0.49	51

25,763.35 41.25 (0.16%)

83,978.49 39.78 ( 0.05%)

58,101.45 325.10 ( 0.56%)

35,653.10 -59.25 ( -0.17%)

47,357.62 -226.25 (-0.48%)

6,873.20 12.00 (0.17%)

52,282.77 957.16 (1.86%)

9,706.66 -10.59 (-0.11%)

88.57 0.35 (0.39%)

102.67 0.05 (0.05%)

116.69 0.04 (0.03%)

0.58 0.00 (-0.51%)